Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.950
-1.210 (-19.64%)
At close: Apr 1, 2025, 4:00 PM
6.67
+1.72 (34.69%)
After-hours: Apr 1, 2025, 5:02 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $78.44 million as of April 1, 2025. Its market cap has increased by 55.85% in one year.
Market Cap
78.44M
Enterprise Value
62.57M
1-Year Change
55.85%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $78.44M, a decrease of -74.87%. That is a compound annual growth rate of -52.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 97.62M | 77.61% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.57B |
| UnitedHealth Group | 479.34B |
| Johnson & Johnson | 399.88B |
| AbbVie | 367.75B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.11B |
| Merck & Co. | 225.37B |